Jagielska , Beata, Andrzej Czubek, Konrad Talasiewicz, Adam Twarowski, Piotr Rutkowski, Maciej Krzakowski, Bianka Saetre, and Marek Malecki. “Assessment of Efficacy of Trastuzumab (Herceptin) Comprising Adjuvant Therapy of HER2+ Breast Cancer Patients Determined Based Upon Statistical Analysis of Overall Survival (OS) and Disease-Free Survival (PFS)”. Molecular Cellular Therapy and Mechanism 6, no. 1 (March 27, 2023): 37–49. Accessed November 13, 2024. https://riverpublishersjournal.com/index.php/MCTM/article/view/211.